Lyra Therapeutics (LYRA) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free LYRA Stock Alerts $0.37 +0.01 (+2.59%) (As of 05:26 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Lyra Therapeutics Stock Price Performance5 Day Performance-3.75%1 Month Performance-92.95%3 Month Performance-92.41%6 Month Performance-87.08%Year-To-Date Performance-92.90%1 Year Performance-86.07% Receive LYRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica could fall from this eventAmerica’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. LYRA Stock Chart for Tuesday, May, 14, 2024 LYRA Chart by TradingView Lyra Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$0.37$0.36-2.66%$0.37$0.362.48 million shs$22.11 million05/10/2024$0.39$0.37-3.62%$0.39$0.363.67 million shs$22.71 million05/09/2024$0.39$0.39-0.85%$0.40$0.365.17 million shs$23.57 million05/08/2024$0.42$0.39-7.19%$0.42$0.387.48 million shs$23.77 million05/07/2024$0.52$0.42-19.46%$0.49$0.4119.01 million shs$25.61 million05/06/2024$4.03$0.52-87.06%$0.64$0.36108.37 million shs$31.80 million Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$4.63$4.03-12.96%$4.71$3.922.44 million shs$245.71 million05/02/2024$5.25$4.63-11.81%$5.26$4.58576,304 shs$282.29 million05/01/2024$5.16$5.25+1.74%$5.65$5.00471,664 shs$313.64 million04/30/2024$4.73$5.16+9.09%$5.20$4.68261,702 shs$308.27 million04/29/2024$4.72$4.73+0.21%$5.02$4.70302,755 shs$282.57 million04/26/2024$5.17$4.72-8.70%$5.20$4.70157,109 shs$281.97 million04/25/2024$5.23$5.17-1.15%$5.28$5.13105,302 shs$308.86 million04/24/2024$5.21$5.23+0.38%$5.42$5.16120,741 shs$312.44 million04/23/2024$5.21$5.21$5.39$5.21228,918 shs$311.25 million04/22/2024$5.19$5.21+0.39%$5.28$5.07240,758 shs$311.25 million04/19/2024$5.39$5.19-3.71%$5.48$5.12233,961 shs$310.05 million04/18/2024$5.41$5.39-0.28%$5.52$5.21387,833 shs$322.00 million04/17/2024$5.40$5.41+0.09%$5.77$5.27299,196 shs$322.90 million04/16/2024$5.27$5.40+2.47%$5.48$5.19244,104 shs$322.61 million04/15/2024$5.28$5.27-0.19%$5.38$5.20240,217 shs$314.83 million04/12/2024$5.44$5.28-2.94%$5.55$5.16264,004 shs$315.43 million04/11/2024$5.25$5.44+3.62%$5.50$5.29269,368 shs$324.99 million04/10/2024$5.24$5.25+0.19%$5.29$4.94237,531 shs$313.64 million04/09/2024$5.10$5.24+2.75%$5.34$5.00377,987 shs$313.04 million04/08/2024$5.02$5.10+1.59%$5.20$5.01175,001 shs$304.67 million04/05/2024$5.28$5.02-4.92%$5.41$5.01423,032 shs$299.90 million04/04/2024$5.46$5.28-3.30%$5.66$5.28299,148 shs$315.43 million04/03/2024$5.61$5.46-2.67%$5.83$5.45264,415 shs$326.18 million04/02/2024$6.25$5.61-10.24%$6.29$5.59216,959 shs$335.14 million04/01/2024$6.22$6.25+0.48%$6.36$5.651.33 million shs$373.38 million03/29/2024$6.22$6.22$6.68$6.201.15 million shs$371.58 million03/28/2024$6.53$6.22-4.75%$6.68$6.201.15 million shs$371.58 million03/27/2024$6.13$6.53+6.53%$6.79$6.16871,452 shs$390.10 million03/26/2024$6.16$6.13-0.49%$6.45$6.06701,568 shs$322.19 million03/25/2024$6.24$6.16-1.28%$6.46$6.15948,387 shs$323.77 million03/22/2024$6.07$6.24+2.80%$6.71$5.81613,102 shs$327.97 million03/21/2024$6.07$6.07$6.19$5.96107,717 shs$319.04 million03/20/2024$6.04$6.07+0.50%$6.23$5.80198,608 shs$319.04 million03/19/2024$5.77$6.04+4.68%$6.09$5.73497,492 shs$317.46 millionDid Intel Just Dethrone Nvidia? (Ad)Intel (INTC) just announced a brand-new AI venture - the Aurora supercomputer. This computer was specifically designed for artificial intelligence and is now the fastest AI-centered computer on the planet. You can get all the details here.03/18/2024$5.93$5.77-2.70%$5.98$5.57209,473 shs$303.27 million03/15/2024$5.73$5.93+3.49%$5.97$5.50389,290 shs$311.68 million03/14/2024$6.41$5.73-10.61%$6.50$5.67265,204 shs$301.17 million03/13/2024$6.19$6.41+3.55%$6.49$6.18157,477 shs$336.91 million03/12/2024$5.66$6.19+9.36%$6.51$5.65429,216 shs$325.37 million03/11/2024$5.31$5.66+6.59%$5.68$5.26172,716 shs$297.49 million03/08/2024$5.49$5.31-3.28%$5.56$5.12232,546 shs$279.09 million03/07/2024$5.49$5.49$5.53$5.32172,241 shs$288.55 million03/06/2024$5.60$5.49-1.96%$5.71$5.45167,550 shs$288.55 million03/05/2024$5.74$5.60-2.44%$5.70$5.31288,674 shs$294.34 million03/04/2024$5.69$5.74+0.88%$5.79$5.51264,242 shs$301.69 million03/01/2024$5.26$5.69+8.17%$5.75$5.22486,750 shs$299.07 million02/29/2024$5.48$5.26-4.01%$5.66$5.21177,551 shs$276.47 million02/28/2024$5.41$5.48+1.29%$5.59$5.36213,899 shs$288.03 million02/27/2024$5.40$5.41+0.19%$5.57$5.33207,863 shs$284.37 million02/26/2024$5.30$5.40+1.89%$5.79$5.22967,361 shs$283.82 million02/23/2024$4.96$5.30+6.85%$5.46$5.041.71 million shs$278.57 million02/22/2024$5.00$4.96-0.80%$5.05$4.90112,160 shs$260.70 million02/21/2024$5.00$5.00$5.07$4.9083,213 shs$262.80 million02/20/2024$5.03$5.00-0.60%$5.08$4.91128,410 shs$262.80 million02/19/2024$5.03$5.03$5.05$4.89129,900 shs$264.38 million02/16/2024$5.00$5.03+0.60%$5.05$4.90129,962 shs$264.38 million02/15/2024$4.90$5.00+2.04%$5.10$4.91241,292 shs$262.80 million02/14/2024$4.82$4.90+1.66%$4.92$4.78107,844 shs$257.54 million02/13/2024$4.87$4.82-1.03%$4.96$4.70440,719 shs$253.34 million Related Companies: PYPD Stock Chart IINN Stock Chart NEPH Stock Chart PAVM Stock Chart MDAI Stock Chart NMTC Stock Chart FEMY Stock Chart AKLI Stock Chart MHUA Stock Chart RVP Stock Chart Receive LYRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LYRA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperDid Intel Just Dethrone Nvidia?Chaikin AnalyticsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAmerica’s worst nightmare?Porter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.